Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | CPT2 | P23786 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29641980 | 0.81 | HMGCR (0.37) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL12515879 | 0.68 | HMGCR (0.34) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL18334444 | 0.67 | HMGCR (0.50) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL18751328 | 0.66 | HMGCR (0.44) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL23316752 | 0.66 | HMGCR (0.35) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL29664400 | 0.62 | ALDH1A1 (0.39) | HMGCRCHRM1TBXA2RADRA1ACPT2 | |
| SCHEMBL18117573 | 0.62 | TSHR (0.39) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL8854080 | 0.60 | HMGCR (0.42) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL12254230 | 0.60 | KDM4E (0.52) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL2710379 | 0.60 | HMGCR (0.42) | HMGCRCHRM1TBXA2RADRA1AFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12385072-B2 | Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids | KHONA SCIENTIFIC HOLDINGS, INC. (US) | 2025-08-12 | — | — | US | claimed |
| US-20250207160-A1 | CELL-FREE PRODUCTION OF GERANYL PYROPHOSPHATE FROM GLYCEROL IN A CELL-FREE MANUFACTURING SYSTEM | Debut Biotechnology, Inc. | 2025-06-26 | — | — | US | claimed |
| EP-3946229-B1 | MICROBIAL ENZYMES TO REDUCE MALODOUR OF SKIN AND TEXTILES | UNIV GENT (BE) | 2025-05-07 | — | — | EP | claimed |
| US-12006528-B2 | Cell-free production of geranyl pyrophosphate from glycerol in a cell-free manufacturing system | Debut Biotechnology, Inc. (US) | 2024-06-11 | — | — | US | claimed |
| EP-4263792-A1 | A VERSATILE CONTINUOUS MANUFACTURING PLATFORM FOR CELL-FREE CHEMICAL PRODUCTION | Debut Biotechnology, Inc. (US) | 2023-10-25 | — | — | EP | claimed |
| EP-4263843-A1 | CELL-FREE PRODUCTION OF GERANYL PYROPHOSPHATE FROM GLYCEROL IN A CELL-FREE MANUFACTURING SYSTEM | Debut Biotechnology, Inc. (US) | 2023-10-25 | — | — | EP | claimed |
| US-20230265465-A1 | BIDIRECTIONAL MULTI-ENZYMATIC SCAFFOLDS FOR BIOSYNTHESIZING CANNABINOIDS | ORLADY, PAUL | 2023-08-24 | — | — | US | claimed |
| EP-2913392-B1 | RECOMBINANT CELL AND PRODUCTION METHOD FOR ISOPRENE | SEKISUI CHEMICAL CO LTD (JP) | 2023-06-07 | — | — | EP | claimed |
| US-11525148-B2 | Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids | KHONA SCIENTIFIC HOLDINGS, INC. (US) | 2022-12-13 | — | — | US | claimed |
| WO-2022133223-A9 | A VERSATILE CONTINUOUS MANUFACTURING PLATFORM FOR CELL-FREE CHEMICAL PRODUCTION | Debut Biotechnology, Inc. (US) | 2022-07-28 | — | — | WO | claimed |
| US-20220195469-A1 | CELL-FREE PRODUCTION OF GERANYL PYROPHOSPHATE FROM GLYCEROL IN A CELL-FREE MANUFACTURING SYSTEM | Debut Biotechnology, Inc. | 2022-06-23 | — | — | US | claimed |
| WO-2022133223-A1 | A VERSATILE CONTINUOUS MANUFACTURING PLATFORM FOR CELL-FREE CHEMICAL PRODUCTION | Debut Biotechnology, Inc. (US) | 2022-06-23 | — | — | WO | claimed |
| WO-2022133213-A1 | CELL-FREE PRODUCTION OF GERANYL PYROPHOSPHATE FROM GLYCEROL IN A CELL-FREE MANUFACTURING SYSTEM | Debut Biotechnology, Inc. (US) | 2022-06-23 | — | — | WO | claimed |
| US-20220193655-A1 | VERSATILE CONTINUOUS MANUFACTURING PLATFORM FOR CELL-FREE CHEMICAL PRODUCTION | Debut Biotechnology, Inc. | 2022-06-23 | — | — | US | claimed |
| US-20260071241-A1 | BIOSYNTHESIS OF ISOPRENOID | AGENCY SCIENCE TECH & RES (SG) | 2026-03-12 | — | — | US | disclosed |
| US-20260062708-A1 | PRODUCTION OF CAROTENOIDS AND APOCAROTENOIDS | AGENCY SCIENCE TECH & RES (SG) | 2026-03-05 | — | — | US | disclosed |
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | Københavns Universitet (DK) | 2026-01-20 | — | — | US | disclosed |
| EP-3980551-A1 | METHODS FOR DECOUPLING YIELD AND PRODUCTIVITY OF A NON-CATABOLIC COMPOUND PRODUCED BY A HOST CELL | Amyris, Inc. (US) | 2022-04-13 | — | — | EP | disclosed |
| US-11299717-B2 | Production of citronellal and citronellol in recombinant hosts | EVOLVA SA (SE) | 2022-04-12 | — | — | US | disclosed |
| CN-114207139-A | Method for uncoupling yield and productivity of non-catabolic compounds produced by a host cell | 阿迈瑞斯公司 | 2022-03-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | GGPS1, OGA, GBA3 | HMGCR 121/4885CHRM1 2893/4885TBXA2R 1677/4885 |
| US-20260071241-A1 | BIOSYNTHESIS OF ISOPRENOID | FADS2, SQLE, VKORC1L1 | HMGCR 118/4885CHRM1 753/4885TBXA2R 148/4885 |
| US-20260062708-A1 | PRODUCTION OF CAROTENOIDS AND APOCAROTENOIDS | HSD17B10, CMBL, HSD11B1 | HMGCR 195/4885CHRM1 3456/4885TBXA2R 3775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.